Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FMI | Ann:Dividend Notification (Price Sensitive) | 12/09/24 | 0 | 104 | |||
|
|||||||
FMI | Ann:2024 Annual Report (Price Sensitive) | 11/09/24 | 0 | 125 | |||
|
|||||||
FMI | Ann:NTA 31 August 2024 | 10/09/24 | 0 | 96 | |||
|
|||||||
FMI | Ann:NTA 31 July 2024 | 23/08/24 | 0 | 142 | |||
|
|||||||
FMI | Ann:NTA 30 June 2024 | 30/07/24 | 0 | 180 | |||
|
|||||||
FMI | Ann:NTA 31 May 2024 | 19/06/24 | 0 | 240 | |||
|
|||||||
FMI | Ann:NTA 30 April 2024 | 13/05/24 | 0 | 280 | |||
|
|||||||
FMI | Ann:NTA 31 March 2024 | 11/04/24 | 0 | 275 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |